A phase II study of infigratinib in previously treated advanced/metastatic cholangiocarcinoma with FGFR gene fusions/alterations Meeting Abstract
| Authors: | Javle, M. M.; Kelley, R. K.; Springfeld, C.; Abou-Alfa, G. K.; Macarulla, T.; Tanasanvimon, S.; Goyal, L.; Borbath, I.; Bitzer, M.; Yong, W. P.; Philip, P. A.; Alvarez-Gallego, R.; Pande, A.; Shepherd, S. P.; Fontaine, J.; Roychowdhury, S. |
| Abstract Title: | A phase II study of infigratinib in previously treated advanced/metastatic cholangiocarcinoma with FGFR gene fusions/alterations |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800041 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS356 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS356 -- Source: Wos |
